Ralph Kern - Brainstorm Cell COO and Chief Medical Officer
| BCLI Stock | USD 0.55 0.02 3.77% |
COO
Dr. Ralph Kern is Chief Operating Officer and Chief Medical Officer of the company. Prior to joining the Company, Dr. Kern was Senior Vice President, Head Worldwide Medical at Biogen Inc. since 2016. Prior positions at Biogen Inc. include Vice President, Head of Global Therapeutic Areas from 2015 to 2016 and Vice President, Head of Global Medical Neurology in 2015 since 2017.
| Age | 66 |
| Tenure | 7 years |
| Address | 1325 Avenue of Americas, New York, NY, United States, 10019 |
| Phone | 201 488 0460 |
| Web | https://www.brainstorm-cell.com |
Brainstorm Cell Management Efficiency
The company has return on total asset (ROA) of (2.117) % which means that it has lost $2.117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.219) %, meaning that it created substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Brainstorm Cell's Return On Capital Employed is increasing as compared to previous years. The Brainstorm Cell's current Return On Equity is estimated to increase to 3.72, while Return On Tangible Assets are projected to decrease to (4.29). The Brainstorm Cell's current Intangibles To Total Assets is estimated to increase to 0.000001, while Total Assets are projected to decrease to under 4 M.Similar Executives
| Found 5 records | COO Age | ||
| Tzvi Palash | Protalix Biotherapeutics | 60 | |
| Scott Young | Aldeyra | 50 | |
| MBA II | Day One Biopharmaceuticals | 47 | |
| Seokho Esq | Terns Pharmaceuticals | 46 | |
| Matthew Winton | Inozyme PharmaInc | 46 | |
Management Performance
| Return On Equity | -11.22 | ||||
| Return On Asset | -2.12 |
Brainstorm Cell Ther Leadership Team
Elected by the shareholders, the Brainstorm Cell's board of directors comprises two types of representatives: Brainstorm Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainstorm. The board's role is to monitor Brainstorm Cell's management team and ensure that shareholders' interests are well served. Brainstorm Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainstorm Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Malcolm Taub, Independent Director | ||
| Mordechai Friedman, Independent Director | ||
| Antal PearlLendner, VP Counsel | ||
| Daniel Offen, Chief Advisor | ||
| Ibrahim MD, Executive Officer | ||
| Alla Patlis, Controller | ||
| Mary Turner, Senior Affairs | ||
| Stacy Lindborg, CoChief Officer | ||
| Ralph Kern, COO and Chief Medical Officer | ||
| Anthony Polverino, Independent Director | ||
| PharmD MBA, Ex COO | ||
| Chen Schor, Independent Director | ||
| June Almenoff, Independent Director | ||
| Eyal Rubin, CFO, Treasurer | ||
| Irit Arbel, Chairman of the Board | ||
| Yael Gothelf, Vice Affairs | ||
| Irit DSc, CoFounder Board | ||
| William White, Senior Pricing | ||
| Arturo Araya, Independent Director | ||
| Uri Yablonka, COO and Director | ||
| Chaim Lebovits, President CoCEO | ||
| Robert Shorr, Independent Director | ||
| Yoram Bibring, CFO | ||
| Marcy Nanus, IR Contact Officer | ||
| Alon Pinkas, Independent Director | ||
| Michael Rice, IR Contact Officer |
Brainstorm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainstorm Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -11.22 | ||||
| Return On Asset | -2.12 | ||||
| Current Valuation | 36.89 M | ||||
| Shares Outstanding | 68.34 M | ||||
| Shares Owned By Insiders | 13.16 % | ||||
| Shares Owned By Institutions | 5.99 % | ||||
| Number Of Shares Shorted | 1.34 M | ||||
| Price To Earning | (16.00) X | ||||
| Price To Book | 65.82 X | ||||
| EBITDA | (21.17 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brainstorm Cell in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brainstorm Cell's short interest history, or implied volatility extrapolated from Brainstorm Cell options trading.
Pair Trading with Brainstorm Cell
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainstorm Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will appreciate offsetting losses from the drop in the long position's value.Moving together with Brainstorm Stock
| 0.66 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.75 | ACB | Aurora Cannabis Trending | PairCorr |
Moving against Brainstorm Stock
| 0.62 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.56 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Brainstorm Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainstorm Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainstorm Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainstorm Cell Therapeutics to buy it.
The correlation of Brainstorm Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainstorm Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainstorm Cell Ther moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainstorm Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Brainstorm Cell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.40) | Return On Assets (2.12) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.